If you wanna catch up on new research in your networks, I recommend this bsky feed! It's great. It shows you posts linking to academic papers - from people you already follow. I've found it very useful so far.
Профиль
Saloni
Профиль VivelyCo-founder & editor, Works in Progress. Writer, Scientific Discovery. Podcaster, Hard Drugs. Advisor, Coefficient Giving. // Previously at Our World in Data. Newsletter: https://scientificdiscovery.dev Podcast: https://harddrugs.worksinprogress.co 🏳️🌈
Nice piece by @wilsonmking.bsky.social on a surprisingly unsolved question: Why are Indian kids so short? (Even more than India's development would imply.) It felt a bit voyeuristic to me though, like reading about myself or something.
This is a really beautiful website by @jdworkin.bsky.social on the everyday household items that were once only dreamt about – a music player, nightlight, family photos, clean water, ice, spices, and more. 10/10 would recommend exploring it! ordinaryabundance.com
Tune in to hear about: Immortal time bias, confounding by selection, regression discontinuities, platform trials, the uncanny mountain of p-values, high-throughput screening, patent and exclusivity laws, push vs pull funding, indication-based pricing, Focused Research Organisations, and more!
SaloniNew episode of HARD DRUGS! GLP1 drugs have transformed obesity & diabetes, help treat heart disease, kidney disease and sleep apnea. They're far from the only drug with multiple uses. But sometimes, it takes several decades - and public funding - to learn about new uses.
New episode of HARD DRUGS! GLP1 drugs have transformed obesity & diabetes, help treat heart disease, kidney disease and sleep apnea. They're far from the only drug with multiple uses. But sometimes, it takes several decades - and public funding - to learn about new uses.
Kalshi recently opened prediction betting markets for clinical trials and drug approvals. It's intriguing, but in my view also risks weakening the integrity of trials and worsening participant dropouts. Short post by me: